Analyst Research

Report Title Price
Provider: Stock Traders Daily
Provider: Stock Traders Daily
Provider: Pechala's Reports
Provider: Thomson Reuters Stock Report

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Edwards Lifesciences Corp Comments On FY 2013 Guidance-Conference Call

Tuesday, 8 Jan 2013 12:00pm EST 

Edwards Lifesciences Corp announced that for fiscal 2013, it expects sales growth to be in 13% to 16% range and earnings per sher (EPS) to grow in excess of 25%. According to I/B/E/S Estimates, analysts are expecting the Company to report revenues of $2.136 billion and EPS of $3.25 for fiscal 2013. 

Company Quote

-0.21 -0.24%
11 Jul 2014